
Chemify, a Blue Yard and Triatomic investment, leverages an innovative platform combining sophisticated robotics, software, and data science to enable a comprehensive digitization of the known and imagined universe of chemicals as the basis for their sophisticated refinement and manufacturing. The platform has myriad applications including specialty chemicals, therapeutics, and AgTech.
While still an amorphous seed-stage company in late 2022, Occam recruited Daniel Delubac, PhD as COO & CTO. Delubac is a technologist and engineer well-versed at conjoining AI, robotics, automation, and biology in the service of developing better therapeutics (Xilis) and diagnostics (Freenome). Key to his success in the role at Chemify will be his almost mystical ability to transmute visionary cutting-edge science into reality at scale. He is a powerful complement to founding scientific CEO Lee Cronin and a catalytic force in his own right. Shortly after joining, Chemify was able to close a substantive A round.
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.